A pragmatic randomised controlled trial of response to an invitation to self-sampling for human papillomavirus (HPV) versus repeat invitation for cervical screening in persistent non-responders in Newcastle upon Tyne

Queen Mary University of London (UK)0 个研究点目标入组 300 人开始时间: 2012年10月4日最近更新: 2016年10月17日

适应症

试验速览

暂无简介。

•Non-responders according to the North East Primary Care Services Agency (NEPCSA) recall process. They will have received their initial screening letter, plus a first reminder letter, plus at least two non-responder cards will have been sent to their General Practitioner, identified using the NEPCSA Exeter National Health Applications and Infrastructure Services (NHAISs) System.

•1. Women who have written to the NEPCSA to document their refusal to take part in the NHSCSP
•2. Women who contact the trial team and ask to be excluded from the trial
•3. Pregnancy
•4. Total abdominal hysterectomy
•5. Never been sexually active
•6. Women who are identified as becoming pregnant or undergoing hysterectomy following the initial test will be excluded from the analysis of data for secondary outcomes
•7. HPV self-sample returned without a signed Informed Consent Form (ICF) (the Participant Information Leaflet (PIL) will state that samples returned without a signed consent form cannot be processed)
•8. Informed Consent Form (ICF) returned with incomplete contact details whereby the test results cannot be sent

发起方

Queen Mary University of London (UK)